Skip to main content
. 2018 Dec 10;18:1534735418817833. doi: 10.1177/1534735418817833

Table 9.

Herbal Hand and Foot Bath Plus Chemotherapy: Chemotherapy-Induced Peripheral Neurotoxicity (CIPN).a

Characteristics (No. of Participants) CIPN Grades III + IV; Effect Size RR [95% CI] I2 CIPN All Grades; Effect Size RR [95% CI] I2 Study ID
FOLFOX4, CRC, first-time chemo after surgery (120) 0.20 [0.01, 4.08] 0.59 [0.36, 0.95]b 11
FOLFOX4, colon cancer, after surgery (44) 1.00 [0.07, 15.00] 0.47 [0.26, 0.86]b 55
Calcium and magnesium + mFOLFOX6, CRC, adjuvant chemotherapy (60) 0.33 [0.01, 7.87] 0.83 [0.61, 1.14] 49.1
mFOLFOX6, CRC, adjuvant chemotherapy (60) 0.20 [0.01, 4.00] 0.96 [0.76, 1.22] 49.2
mFOLFOX6, colon cancer, after surgery (40) 0.33 [0.04, 2.94] 0.47 [0.24, 0.89]b 9
XELOX, CRC, first time received oxaliplatin treatment (50) 0.25 [0.03, 2.08] 0.40 [0.19, 0.86]b 2
Total pool, 5 RCTs, 6 comparisons (374) 0.35 [0.10, 1.20] 0% 0.69 [0.50, 0.95]b 68.8% All above
Sensitivity 1, 5 RCTs, 5 comparisons (314)c 0.32 [0.11, 0.99]b 0% 0.58 [0.37, 0.91]b 75% 2, 9, 11, 49.2, 55
Sensitivity 2, 4 RCTs, 4 comparisons (254)d 0.35 [0.10, 1.17] 0% 0.50 [0.37, 0.67]b 0% 2, 9, 11, 55

Abbreviations: CI, confidence interval; RR, relative risk; RCT, randomized controlled trial.

a

All studies used herbal hand and foot baths combined with chemotherapy versus the same chemotherapy.

b

Statistically significant.

c

Sensitivity 1 excluded Study No. 49 group T1 to remove double counting due to this study having 2 comparisons.

d

Sensitivity 2 excluded Study No. 49 altogether (groups T1 and T2).